Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Targeting ROS in cancer: rationale and strategies

Targeting the Redox Landscape in Cancer Therapy

Mitochondrial Redox Signaling And Tumor Progression

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer

Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy

Reactive Oxygen Species: A Key Constituent in Cancer Survival

Induction of Reactive Oxygen Species: an Emerging Approach for Cancer Therapy

High-throughput screening of cellular redox sensors using modern redox proteomics approaches

Advances in Reactive Oxygen Species Responsive Anti-cancer Prodrugs

ROS signalling in the biology of cancer

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Redox regulation and its emerging roles in cancer treatment

Modulation of redox signal transduction pathways in the treatment of cancer

Methods for Detection of Mitochondrial and Cellular Reactive Oxygen Species

Sensors, Imaging Agents, and Theranostics to Help Understand and Treat Reactive Oxygen Species Related Diseases

Metabolic Regulation of Redox Balance in Cancer

Modulation of reactive oxygen species in cancers: recent advances

Generation and Application of Reactive Oxygen Radicals in Cancer Treatment